NCT07555327Completed
Clinical Observation of Renal Function Reactivation Following a GRAS-Based Protocol in Patients With Chronic Kidney Disease and Long-Term Renal Arrest.
Source: ClinicalTrials.gov · Last updated 27 May 2026
Brief summary (registry, in English)
This observational study documents the impact of a specific oral protocol (based on FDA-GRAS ingredients) on patients with Stage 5 Chronic Kidney Disease (CKD). The study observes 8 participants, including 6 with residual renal function and 2 patients with long-term total renal arrest (16 years and 22 years of anuria). The primary focus is monitoring the restoration of urine output and changes in renal biological markers.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 8 (actual)
- First submitted
- 20 Apr 2026
- Start date
- 2 Feb 2026
- Primary completion date
- 15 Apr 2026
- Lead sponsor
- Amar h Zireg
- NCT number
- NCT07555327
What you commit to
- Study type: Observational
- Participants enrolled: 8
- From 2 Feb 2026 to the primary completion date, 15 Apr 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Pregnant women
Criteria the registry did not label
- Sampling Method: Non-Probability Sample
- Criteria: Patients with confirmed Stage 5 CKD on or off dialysis, with documented periods of renal inactivity ranging from residual function to 20+ years of total arrest.ion Criteria:
- Aged 18 and older" et "Diagnosed with ESRD (End-Stage Renal Disease)".
Sex: Male
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Amar hocine Zireg Coordinator of this site? Confirm its status | Bordj Bou Arreridj | Algeria | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.